Quent Capital’s Integra LifeSciences IART Stock Holding History

Quent Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-484	Closed	-$6.94K	–	1593
2025 Q3	$6.94K	Buy	+484	New	+$6.63K	﹤0.01%	1086
2025 Q2	–	Sell	-18	Closed	-$396	–	736
2025 Q1	$396	Hold	18	–	–	﹤0.01%	1262
2024 Q4	$408	Hold	18	–	–	﹤0.01%	1280
2024 Q3	$327	Hold	18	–	–	﹤0.01%	1316
2024 Q2	$525	Sell	18 -289	-94%	-$8.57K	﹤0.01%	1291
2024 Q1	$10.9K	Buy	307 +49	+19%	+$1.96K	﹤0.01%	1002
2023 Q4	$11.2K	Buy	258 +18	+8%	+$708	﹤0.01%	950
2023 Q3	$9.17K	Buy	+240	New	+$10.1K	﹤0.01%	948
2023 Q2	–	Sell	-20	Closed	-$1.15K	–	1337
2023 Q1	$1.15K	Hold	20	–	–	﹤0.01%	1232
2022 Q4	$1.12K	Sell	20 -100	-83%	-$5.09K	﹤0.01%	1216
2022 Q3	$5K	Hold	120	–	–	﹤0.01%	977
2022 Q2	$6K	Hold	120	–	–	﹤0.01%	917
2022 Q1	$8K	Buy	120 +20	+20%	+$1.32K	﹤0.01%	948
2021 Q4	$7K	Buy	+100	New	+$6.76K	﹤0.01%	870

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Quent Capital's IART Position: Q4 2025 in Review

Quent Capital sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 484 shares — an estimated $6.94K sold.

Quent Capital first reported a position in IART in Q4 2021 and held it in 14 quarters. The position peaked at $11.2K in Q4 2023. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

Quent Capital reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
Quent Capital sold 484 Integra LifeSciences shares in Q4 2025, an estimated $6.94K.
Quent Capital first reported a position in Integra LifeSciences in Q4 2021 and held it in 14 quarters.
Quent Capital's Integra LifeSciences position peaked at $11.2K in Q4 2023.
204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Quent Capital's 13F filing for Q4 2025, filed 29 Jan 2026.